Literature DB >> 12118343

CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7.

Fei Wu1, Jiro Fujita, Masayuki Murota, Jia-Qing Li, Toshihiko Ishida, Mikio Nishioka, Yuji Imaida, Shigeki Kuriyama.   

Abstract

Many types of cancer cells widely express cytokeratin 19 (CK19). Clinical investigations have suggested that serum CYFRA 21-1, a fragment of CK19, is one of the most useful tumor markers. In the present study, we hypothesized that released CYFRA 21-1 is closely associated with cellular apoptosis during tumor growth. Apoptosis was induced by tumor necrosis factor-alpha (TNF-alpha) in the HuH-7 hepatocellular carcinoma cell line. Both TNF-alpha-treated and non-treated cells of HuH-7 were simultaneously examined by immunoradiometric assay, annexin-V apoptosis analysis, immunohistochemical staining and colorimetric protease measurement. Levels of CYFRA 21-1 increased significantly in TNF-alpha-treated cells displaying a high percentage of apoptosis, granular-like aggregation of CK19, and elevated activity of caspase-3 in contrast to non-treated cells. Levels of CYFRA 21-1 decreased significantly after caspase-3 was inhibited in TNF-alpha-treated cells. Thus, the release of CYFRA 21-1 may suggest cellular apoptosis in the process of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118343

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients.

Authors:  Yan Li; Zhao-You Tang; Bo Tian; Sheng-Long Ye; Lun-Xiu Qin; Qiong Xue; Rui-Xia Sun
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-19       Impact factor: 4.553

2.  A novel immunoassay for the quantization of CYFRA 21-1 in human serum.

Authors:  An He; Tian-Cai Liu; Zhi-Ning Dong; Zhi-Qi Ren; Jing-Yuan Hou; Ming Li; Ying-Song Wu
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

3.  Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours.

Authors:  Renee G H M van Sprundel; Ted S G A M van den Ingh; Valeer J Desmet; Azeam Katoonizadeh; Louis C Penning; Jan Rothuizen; Tania Roskams; Bart Spee
Journal:  Comp Hepatol       Date:  2010-02-18

4.  CYFRA 21-1 in urine: a diagnostic marker for endometriosis?

Authors:  Risto Gjavotchanoff
Journal:  Int J Womens Health       Date:  2015-02-09

5.  Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer.

Authors:  L Giovanella; M Imperiali; P Trimboli
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

6.  Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer.

Authors:  Sumeet Suresh Malapure; Chetan D Patel; R Lakshmy; Chandrashekhar Bal
Journal:  Indian J Nucl Med       Date:  2020-03-12

7.  Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Authors:  T Uenishi; S Kubo; K Hirohashi; H Tanaka; T Shuto; T Yamamoto; S Nishiguchi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.